May 2022 News & Views: Quarterly Strategic Priorities Update; Access the Newly Expanded Drug Product Pipeline; New Member Benefit! Interactive State Policy Map; Earn Free CPE During eLearning Days, May 10–12.
April 2022 News & Views: Thank You for Joining Us for AMCP 2022; Register Today to Join Health Care Leaders in Addressing Health Disparities; AMCP Statement on the Introduction of the Access to Prescription Digital Therapeutics Act of 2022; Make an Impact at Nexus 2022 — Submit a Session Proposal or Poster Abstract; AMCP Names Mason Johnson 2022-2023 Executive Fellow in Health Care Association Leadership.
March 2022 News & Views: New AMCP CEO Blog: Get Inspired at AMCP 2022 in Chicago; Pharmacoequity: A New Opportunity for ManagedCare Pharmacy; Mark Your Calendar for the AMCP Health DisparitiesSummit on June 9; Explore Education Opportunities at AMCP 2022.
On April 27, AMCP joined a broad coalition of health care stakeholders in urging Congressional leaders to protect American's access to COVID-19 testing, treatments, and vaccines, regardless of insurance status - by replenishing the COVID-19 Uninsured Relief Fund.
Partnership Forum: The purpose of the forum was to identify concerns for high-investment medications related to predictability, affordability, and accessibility. Participants also explored alternative payments, financial tools, and policy initiatives related to these medications.
Oncology is a specialization that involves the management of drug treatments for people with early and advanced cancers that affect the organs, muscles, bones and connective tissue. However, people with some early-stage cancers may be treated with surgery or radiation therapy alone and may not need the care of an oncologist.
